US Stock MarketDetailed Quotes

UNCY Unicycive Therapeutics

Watchlist

0.7999
+0.0003+0.04%

Trading Dec 30 14:42 ET

86.73MMarket Cap-1.74P/E (TTM)

Unicycive Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Unicycive Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
--	2024/Q3	0.000 / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

--2024/Q30.000 / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Unicycive Therapeutics Earnings Reports

Unicycive Therapeutics | 8-K: Unicycive Announces Third Quarter 2024 Financial Results and Provides Business Update

Nov 13 08:07 ET

Unicycive Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 13 07:08 ET

Unicycive Therapeutics | 8-K: Unicycive Announces Second Quarter 2024 Financial Results and Provides Business Update

Aug 14 08:14 ET

Unicycive Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 14 07:09 ET

Analyst Rating

Updated: Dec 30, 2024

Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall